Pasi Antero Janne

This inventor holds 32 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 14 EPO patents, primarily in Cancer Therapeutics. Top assignees: Dana-Farber-Cancer Institute Inc., The General Hospital Corporation, Beth Israel Deaconess Medical Center, Inc.. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pasi Antero Janne. Retrieved from https://idiyas.com/inventor/pasi-antero-janne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 17)

% Patents Active = 93.8

CIPO Patents = 2 (Patent Applications = 8)

EPO Patents = 14 (Patent Applications = 10)

Average Co-Inventor Count = 5.3

ph-index = 7

Forward Citations = 496(Granted Patents)

Location History:

Nedham, MA (US) (2019)
Newton, MA (US) (2007 - 2024)
Needham, MA (US) (2017 - 2024)

Company Filing History:

32 out of 1,268

Dana-Farber-Cancer Institute Inc.

patents

11 out of 3,076

The General Hospital Corporation

patents

2 out of 539

Beth Israel Deaconess Medical Center, Inc.

The University of North Carolina at Chapel Hill

patents

6. 1 out of 5,640

The University of Texas System

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

EGFR Inhibitors

HER2 Targeting

ALK Degradation

Pyrimidines

Cancer Treatment

Biomarkers

Non-invasive Monitoring

Genomic Alterations

Protein Degradation

Therapeutic Methods

Oncology

Diagnostics

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331037 - Pyrimidines as EGFR-inhibitors and methods of treating disorders (2025-06-17),

2. 12233128 - Degraders that target ALK and therapeutic uses thereof (2025-02-25),

3. 12006555 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments (2024-06-11),

4. 11945816 - Inhibitors of EGFR and/or HER2 and methods of use (2024-04-02),

5. 11858897 - Substituted 6,11-dihydro-5H-benzo[b]carbazoles as inhibitors of ALK and SRPK (2024-01-02),

6. 11814379 - Cyano quinoline amide compounds as HER2 inhibitors and methods of use (2023-11-14),

7. 11673882 - Pyrimidines as EGFR inhibitors and methods of treating disorders (2023-06-13),

8. 11584746 - Inhibitors of EGFR and methods of use thereof (2023-02-21),

9. 11186574 - Inhibitors of EGFR and/or HER2 and methods of use (2021-11-30),

10. 11161842 - Bifunctional molecules for degradation of EGFR and methods of use (2021-11-02),

11. 11066363 - Substituted 6,11-dihydro-5H-benzo[B]carbazoles as inhibitors of ALK and SRPK (2021-07-20),

12. 11009508 - Methods of diagnosing and prognosing lung cancer (2021-05-18),

13. 11008620 - Methods for treating cancer resistant to ErbB therapeutics (2021-05-18),

14. 10870636 - Pyrimidines as EGFR inhibitors and methods of treating disorders (2020-12-22),

15. 10865451 - Non-invasive blood based monitoring of genomic alterations in cancer (2020-12-15),

Title: The Innovative Mind of Pasi Antero Janne

Introduction: Pasi Antero Janne is a pioneering inventor based in Newton, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Pasi Antero Janne's most recent patents include advancements in nanotechnology, renewable energy, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Pasi Antero Janne has established himself as a leading figure in the innovation landscape. His work has not only revolutionized existing technologies but has also paved the way for new developments in the industry.

Collaborations: Throughout his career, Pasi Antero Janne has collaborated with top research institutions, leading companies, and brilliant minds in the field. These collaborations have been instrumental in bringing his visionary ideas to life and making a significant impact on the world.

Conclusion: Pasi Antero Janne's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his position as a true trailblazer in the world of inventions. His work continues to inspire future generations of inventors and researchers to think boldly and create fearlessly.

Profile summary based on public USPTO records.